These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27737895)

  • 1. High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on Hemodialysis.
    Chen CW; Drechsler C; Suntharalingam P; Karumanchi SA; Wanner C; Berg AH
    Clin Chem; 2017 Feb; 63(2):477-485. PubMed ID: 27737895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new association.
    Hoshino J; Abe M; Hamano T; Hasegawa T; Wada A; Nakai S; Hanafusa N; Masakane I; Nitta K
    Nephrol Dial Transplant; 2023 May; 38(5):1309-1317. PubMed ID: 36309475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
    Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
    J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.
    Hoshino J; Hamano T; Abe M; Hasegawa T; Wada A; Ubara Y; Takaichi K; Inaba M; Nakai S; Masakane I;
    Nephrol Dial Transplant; 2018 Jul; 33(7):1150-1158. PubMed ID: 29528439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis.
    Freedman BI; Shenoy RN; Planer JA; Clay KD; Shihabi ZK; Burkart JM; Cardona CY; Andries L; Peacock TP; Sabio H; Byers JR; Russell GB; Bleyer AJ
    Perit Dial Int; 2010; 30(1):72-9. PubMed ID: 20056983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated Albumin Predicts Long-term Survival in Patients Undergoing Hemodialysis.
    Lu CL; Ma WY; Lin YF; Shyu JF; Wang YH; Liu YM; Wu CC; Lu KC
    Int J Med Sci; 2016; 13(5):395-402. PubMed ID: 27226780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
    Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
    J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum albumin-adjusted glycated albumin as a better indicator of glycemic control in Type 2 diabetes mellitus patients with short duration of hemodialysis.
    Yajima T; Yajima K; Hayashi M; Takahashi H; Yasuda K
    Diabetes Res Clin Pract; 2017 Aug; 130():148-153. PubMed ID: 28641154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients' conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study.
    Hoshino J; Abe M; Hamano T; Hasegawa T; Wada A; Ubara Y; Takaichi K; Nakai S; Masakane I; Nitta K
    BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33099507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.
    Isshiki K; Nishio T; Isono M; Makiishi T; Shikano T; Tomita K; Nishio T; Kanasaki M; Maegawa H; Uzu T;
    Ther Apher Dial; 2014 Oct; 18(5):434-42. PubMed ID: 24251784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control and survival in peritoneal dialysis patients with diabetes: A 2-year nationwide cohort study.
    Abe M; Hamano T; Hoshino J; Wada A; Nakai S; Masakane I
    Sci Rep; 2019 Mar; 9(1):3320. PubMed ID: 30824808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of atherosclerosis on the relationship of glycemic control and mortality in diabetic patients on hemodialysis.
    Inaba M; Maekawa K; Okuno S; Imanishi Y; Hayashino Y; Emoto M; Shoji T; Ishimura E; Yamakawa T; Nishizawa Y
    Clin Nephrol; 2012 Oct; 78(4):273-80. PubMed ID: 22541674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse association of fat mass, but not lean mass, with glycated albumin in hemodialysis patients with or without diabetes mellitus.
    Miyawaki J; Okuno S; Mori K; Nishio E; Norimine K; Kurajoh M; Yamakawa T; Shoji S; Inaba M
    Ren Fail; 2019 Nov; 41(1):808-813. PubMed ID: 31498022
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis.
    Murea M; Moran T; Russell GB; Shihabi ZK; Byers JR; Andries L; Bleyer AJ; Freedman BI
    Am J Nephrol; 2012; 36(5):488-96. PubMed ID: 23147746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Glycated Hemoglobin and Albumin-Corrected Glycated Serum Protein on Mortality in Diabetic Patients Receiving Continuous Peritoneal Dialysis.
    Peng F; Xia X; He F; Li Z; Huang F; Yu X
    Perit Dial Int; 2015; 35(5):566-75. PubMed ID: 25395497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
    Ushigome E; Matsusaki S; Watanabe N; Hashimoto T; Nakamura N; Fukui M
    J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.